ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SNT Senesco Technologies

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Senesco Technologies AMEX:SNT AMEX Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Emerging Biotech Companies Discuss What’s in the Pipeline at NYSSA Conference

10/11/2011 3:00pm

Business Wire


Senesco (AMEX:SNT)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Senesco Charts.

Insiders from some of the sector’s most innovative small- and micro-cap biotech companies will discuss their progress with trials and their plans to develop, research, and market important new drugs, diagnostics and delivery technologies at the New York Society of Security Analysts’ 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011.

The agenda also includes an outlook on the industry from Yigal D. Nochomovitz, PhD, senior biotechnology analyst and senior vice president at Rodman & Renshaw, LLC.

A 2011 study indicated that the majority of investors expect that biotech will outperform the overall healthcare sector in 2011 and 2012, with just over one-third forecasting double-digit returns. NYSSA has brought together executives from these emerging biotech companies who will give 35-minute presentations on their company’s prospects to members of the Wall Street community:

  • Cardio3BiosciencesChristian Homsy, CEO
  • DARA BioSciences, Inc. (Nasdaq: DARA)Richard A. Franco, President, CEO and Chairman
  • EpiCept Corporation (Nasdaq: EPTC)Jack Talley, President and CEO
  • Galena Biopharma (Nasdaq: RXII)Mark Schwartz, PhD, EVP and COO
  • NanoViricides, Inc.Eugene Seymour, MD, MPH, CEO
  • OncoSec Medical Inc.Punit Dhillon, President and CEO
  • Provectus Pharmaceuticals, Inc. (OTC: PVCT)Craig Dees, PhD, CEO
  • Senesco Technologies (AMEX: SNT)Leslie J. Browne, President and CEO
  • TONIX Pharmaceuticals (OTCBB: TNXP)Dr. Seth Lederman, President and Chairman

The full-day conference will be held on November 30, 2011 from 8:30 a.m.–4:10 p.m. at NYSSA Conference Center, 1540 Broadway, Suite 1010, New York, NY 10036.

For more information on the conference, please visit: www.nyssa.org/biotech.

There is no charge for press with credentials.

About NYSSA

The New York Society of Security Analysts (NYSSA) is a leading forum for the investment community. NYSSA’s mission is to promote best practices and the highest professional and ethical standards in the industry. With 10,000 members, NYSSA is the largest of the 135 societies worldwide that make up CFA Institute, which has over 105,000 members. For more information about NYSSA, please visit http://www.nyssa.org. Follow NYSSA on Facebook, Twitter and Finance Professionals’ Post.

1 Year Senesco Chart

1 Year Senesco Chart

1 Month Senesco Chart

1 Month Senesco Chart

Your Recent History

Delayed Upgrade Clock